Probing hot spots at protein-ligand binding sites: a fragment-based approach using biophysical methods.

Mapping interactions at protein-ligand binding sites is an important aspect of understanding many biological reactions and a key part of drug design. In this paper, we have used a fragment-based approach to probe "hot spots" at the cofactor-binding site of a model dehydrogenase, Escherichia coli ketopantoate reductase. Our strategy involved the breaking down of NADPH (Kd = 300 nM) into smaller fragments and the biophysical characterization of their binding using WaterLOGSY NMR spectroscopy, isothermal titration calorimetry (ITC), and inhibition studies. The weak binding affinities of fragments were measured by direct ITC titrations under low c value conditions. The 2'-phosphate and the reduced nicotinamide groups were found to contribute a large part of the binding energy. A combination of ITC and site-directed mutagenesis enabled us to locate the fragments at separate hot spots on opposite ends of the cofactor-binding site. This study has identified structural determinants for cofactor recognition that represent a blueprint for future inhibitor design.

[1]  A. Kornberg,et al.  The extinction coefficients of the reduced band of pyridine nucleotides. , 1948, The Journal of biological chemistry.

[2]  R. Bock,et al.  Ultraviolet absorption spectra of adenosine-5'-triphosphate and related 5'-ribonucleotides. , 1956, Archives of biochemistry and biophysics.

[3]  G. A. Montgomery,et al.  Ultraviolet absorption spectra of DPN and analogs of DPN. , 1959, Archives of biochemistry and biophysics.

[4]  P. Terpstra,et al.  Prediction of the Occurrence of the ADP-binding βαβ-fold in Proteins, Using an Amino Acid Sequence Fingerprint , 1986 .

[5]  J. Morrison,et al.  Mechanism of the reaction catalyzed by dihydrofolate reductase from Escherichia coli: pH and deuterium isotope effects with NADPH as the variable substrate. , 1988, Biochemistry.

[6]  J F Brandts,et al.  Rapid measurement of binding constants and heats of binding using a new titration calorimeter. , 1989, Analytical biochemistry.

[7]  A. G. Tahiliani,et al.  Pantothenic acid in health and disease. , 1991, Vitamins and hormones.

[8]  V. Saudek,et al.  Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions , 1992, Journal of biomolecular NMR.

[9]  R. Liu,et al.  A novel preparation of nicotinamide mononucleotide. , 1994, Nucleosides & nucleotides.

[10]  A G Murzin,et al.  SCOP: a structural classification of proteins database for the investigation of sequences and structures. , 1995, Journal of molecular biology.

[11]  A M Lesk,et al.  NAD-binding domains of dehydrogenases. , 1995, Current opinion in structural biology.

[12]  Z. Zhang,et al.  Low-affinity binding determined by titration calorimetry using a high-affinity coupling ligand: a thermodynamic study of ligand binding to protein tyrosine phosphatase 1B. , 1998, Analytical biochemistry.

[13]  R M Stroud,et al.  The additivity of substrate fragments in enzyme-ligand binding. , 1998, Structure.

[14]  I. Kuntz,et al.  The maximal affinity of ligands. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[15]  D. Kostrewa,et al.  Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening. , 2000, Journal of medicinal chemistry.

[16]  M. Sundström,et al.  Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water* , 2000, Journal of biomolecular NMR.

[17]  B. Sigurskjold,et al.  Exact analysis of competition ligand binding by displacement isothermal titration calorimetry. , 2000, Analytical biochemistry.

[18]  R. Zheng,et al.  Kinetic and mechanistic analysis of the E. coli panE-encoded ketopantoate reductase. , 2000, Biochemistry.

[19]  E. Strauss,et al.  The biosynthesis of coenzyme A in bacteria. , 2001, Vitamins and hormones.

[20]  J M Thornton,et al.  On the molecular discrimination between adenine and guanine by proteins. , 2001, Nucleic acids research.

[21]  T. Blundell,et al.  Crystal structure of Escherichia coli ketopantoate reductase at 1.7 A resolution and insight into the enzyme mechanism. , 2001, Biochemistry.

[22]  G. Holdgate,et al.  Isothermal titration calorimetry in drug discovery. , 2001, Progress in medicinal chemistry.

[23]  G. J. Swaminathan,et al.  Mapping the Ribonucleolytic Active Site of Eosinophil-derived Neurotoxin (EDN) , 2001, The Journal of Biological Chemistry.

[24]  Claudio Dalvit,et al.  NMR screening techniques in drug discovery and drug design , 2002 .

[25]  H. Jhoti,et al.  Structure-based screening of low-affinity compounds. , 2002, Drug discovery today.

[26]  D. Baker,et al.  A simple physical model for binding energy hot spots in protein–protein complexes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Harren Jhoti,et al.  High-throughput crystallography for lead discovery in drug design , 2002, Nature Reviews Drug Discovery.

[28]  W. Delano.  Unraveling hot spots in binding interfaces: progress and challenges. , 2002, Current opinion in structural biology.

[29]  Marcel L. Verdonk,et al.  The consequences of translational and rotational entropy lost by small molecules on binding to proteins , 2002, J. Comput. Aided Mol. Des..

[30]  Jeremy Bruenn,et al.  Rational proteomics I. Fingerprint identification and cofactor specificity in the short‐chain oxidoreductase (SCOR) enzyme family , 2003, Proteins.

[31]  R. Zheng,et al.  Substrate specificity and kinetic isotope effect analysis of the Eschericia coli ketopantoate reductase. , 2003, Biochemistry.

[32]  B. Shoichet,et al.  A specific mechanism of nonspecific inhibition. , 2003, Journal of medicinal chemistry.

[33]  W Bruce Turnbull,et al.  On the value of c: can low affinity systems be studied by isothermal titration calorimetry? , 2003, Journal of the American Chemical Society.

[34]  T. O'Brien,et al.  Fragment-based drug discovery. , 2004, Journal of medicinal chemistry.

[35]  A. Hopkins,et al.  Ligand efficiency: a useful metric for lead selection. , 2004, Drug discovery today.

[36]  Michelle R Arkin,et al.  Integrating fragment assembly and biophysical methods in the chemical advancement of small-molecule antagonists of IL-2: an approach for inhibiting protein-protein interactions. , 2004, Journal of medicinal chemistry.

[37]  Michelle R. Arkin,et al.  Small-molecule inhibitors of protein–protein interactions: progressing towards the dream , 2004, Nature Reviews Drug Discovery.

[38]  C. Abell,et al.  Biosynthesis of pantothenate. , 2004, Natural product reports.

[39]  Paul J Lewi,et al.  Concentration and pH dependent aggregation of hydrophobic drug molecules and relevance to oral bioavailability. , 2005, Journal of medicinal chemistry.

[40]  C. Abell,et al.  Biophysical tools to monitor enzyme-ligand interactions of enzymes involved in vitamin biosynthesis. , 2005, Biochemical Society transactions.

[41]  Christopher W Murray,et al.  Fragment-based lead discovery using X-ray crystallography. , 2005, Journal of medicinal chemistry.

[42]  Tomas Lundqvist.  The devil is still in the details--driving early drug discovery forward with biophysical experimental methods. , 2005, Current opinion in drug discovery & development.

[43]  Christopher W Murray,et al.  Fragment-based lead discovery: leads by design. , 2005, Drug discovery today.

[44]  Christopher W Murray,et al.  Identification of novel p38alpha MAP kinase inhibitors using fragment-based lead generation. , 2005, Journal of medicinal chemistry.

[45]  G. Holdgate,et al.  Measurements of binding thermodynamics in drug discovery. , 2005, Drug discovery today.

[46]  P. Hajduk,et al.  Druggability indices for protein targets derived from NMR-based screening data. , 2005, Journal of medicinal chemistry.

[47]  P. Hajduk,et al.  Utilization of NMR-derived fragment leads in drug design. , 2005, Methods in enzymology.

[48]  T. Blundell,et al.  The crystal structure of Escherichia coli ketopantoate reductase with NADP+ bound. , 2005, Biochemistry.